Disclosed are methods for treating cancer such as a myeloid malignancy such as multiple myeloma in a human using EZH2 inhibitors in human populations having a translocation MMSET or a decreased level of a functional UTX protein or both.
申请公布号
WO2015143424(A2)
申请公布日期
2015.09.24
申请号
WO2015US21905
申请日期
2015.03.21
申请人
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED;NORTHWESTERN, UNIVERSITY
